Brian G. Atwood
Director, PHARMION CORP.
Companies
- CERO THERAPEUTICS HOLDINGS, INC.Board member Oct 5, 2021 to now1
- Launch One Acquisition Corp.Board member Jul 11, 2024 to Jul 11, 20242
- CERO THERAPEUTICS HOLDINGS, INC.Chief executive officer Feb 16, 2024 to Mar 27, 20243
- Atreca, Inc.Board member Jun 19, 2019 to Jun 15, 20234
- Clovis OncologyBoard member Nov 15, 2011 to Jun 11, 20215
- eFFECTOR Therapeutics, Inc.Board member Jan 7, 2021 to Jan 14, 20216
- OpGen (United States)Board member May 6, 2015 to Jun 24, 20167
- VERACYTE, INC.Board member Oct 29, 2013 to Jun 20, 20168
- Flexion TherapeuticsBoard member Sep 12, 2014 to Sep 12, 20149
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CERO THERAPEUTICS HOLDINGS, INC. CERO491,784 shares10$3.0K at $0.01Apr 4, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 31, 2025Exercised options 294,460 shares of CERO THERAPEUTICS HOLDINGS, INC.10
- Sep 25, 2024Exercised options 19,358,578 shares of CERO THERAPEUTICS HOLDINGS, INC.11
- Feb 14, 2024Other 148,208 shares of CERO THERAPEUTICS HOLDINGS, INC.12
- Feb 14, 2024Other 148,208 shares of CERO THERAPEUTICS HOLDINGS, INC.13
- Feb 14, 2024Other 148,208 shares of CERO THERAPEUTICS HOLDINGS, INC.14
- Feb 14, 2024Other 100,527 shares of CERO THERAPEUTICS HOLDINGS, INC.12
- Feb 14, 2024Other 100,527 shares of CERO THERAPEUTICS HOLDINGS, INC.13
- Feb 14, 2024Other 100,527 shares of CERO THERAPEUTICS HOLDINGS, INC.14
- Feb 14, 2024Other 125,000 shares of CERO THERAPEUTICS HOLDINGS, INC.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAtreca, Inc., Board member
- 5SEC EDGARClovis Oncology, Board member
- 6
- 7SEC EDGAROpGen (United States), Board member
- 8SEC EDGARVERACYTE, INC., Board member
- 9SEC EDGARFlexion Therapeutics, Board member
- 10
- 11SEC EDGARForm 4 filed Oct 2, 2024
- 12SEC EDGARForm 4 filed Feb 16, 2024
- 13SEC EDGARForm 4 filed Mar 11, 2024
- 14SEC EDGARForm 4 filed Feb 21, 2024